See original article:
In the 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care section, “Part 7.3: Management of Symptomatic Bradycardia and Tachycardia,” which published ahead of print on November 28, 2005, and appeared in the December 13, 2005, issue of the journal (Circulation. 2005;112:IV-67–IV-77), 2 corrections are needed.
On page IV-76, in the first column, the last paragraph under the heading “Sotalol,” the reference number for the third sentence is 45. It should be reference 49.
On page IV-77, in the second column, the following should be added as reference 49: Marill KA, Runge T. Meta-analysis of the risk of torsades de pointes in patients treated with intravenous racemic sotalol. Acad Emerg Med. 2001;8:117–124.